CONMED Corporation Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	317.0M	373.5M	338.6M	343.0M	319.4M	345.9M	316.7M	332.1M
Cost of Goods Sold	133.6M	160.1M	180.6M	162.5M	151.5M	147.6M	137.7M	148.4M
Gross Profit	183.4M	213.3M	158.0M	180.5M	167.9M	198.3M	179.0M	183.7M
R&D Expenses	16.3M	14.9M	13.9M	14.1M	12.9M	13.2M	13.6M	14.1M
Operating Expenses	158.0M	146.5M	138.6M	138.8M	156.4M	145.8M	113.3M	136.6M
Operating Income	25.4M	66.9M	19.4M	41.7M	11.5M	52.5M	65.7M	47.1M
Other Income / Gains	-7.1M	-37.6M	-15.1M	-11.8M	-3.8M	-8.9M	-9.3M	-9.6M
Net Income	13.8M	16.7M	2.9M	21.4M	6.0M	33.8M	49.0M	30.0M
EPS (Diluted)	0.45	0.54	0.092	0.69	0.19	1.09	1.59	0.97
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.579	0.571	0.467	0.526	0.526	0.573	0.565	0.553
General And Administrative Expenses	141.7M	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	141.7M	131.6M	124.7M	124.7M	143.5M	132.7M	99.7M	122.5M
Other Expenses	0	0	0	0	0	0	0	0
Cost And Expenses	291.6M	306.6M	319.2M	301.3M	307.9M	293.4M	251.0M	285.0M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	7.1M	7.4M	7.6M	7.8M	8.3M	8.9M	9.3M	9.6M
Depreciation And Amortization	12.9M	18.9M	13.1M	13.2M	12.9M	18.0M	18.0M	17.8M
Ebitda	38.3M	55.5M	25.0M	50.9M	28.9M	70.5M	83.7M	64.9M
Ebitdaratio	0.121	0.149	0.074	0.148	0.09	0.204	0.264	0.196
Operating Income Ratio	0.08	0.179	0.057	0.122	0.036	0.152	0.207	0.142
Income Before Tax	18.4M	29.3M	4.3M	29.9M	7.7M	43.6M	56.5M	37.5M
Income Before Tax Ratio	0.058	0.078	0.013	0.087	0.024	0.126	0.178	0.113
Income Tax Expense	4.5M	12.5M	1.4M	8.5M	1.6M	9.9M	7.5M	7.5M
Net Income Ratio	0.044	0.045	0.008	0.062	0.019	0.098	0.155	0.09
Epsdiluted	0.45	0.54	0.092	0.69	0.19	1.08	1.57	0.96
Weighted Average Shs Out	30.6M	31.0M	31.0M	30.9M	31.0M	30.9M	30.9M	30.8M
Weighted Average Shs Out Dil	30.6M	31.0M	31.1M	31.1M	31.2M	31.1M	31.1M	31.1M